文献速递中医内科中药与中成药合理使用

桂枝茯苓丸通过抑制STAT3阻断癌相关间充质干细胞促卵巢癌进展

Guizhi-Fuling Wan suppresses carcinoma-associated mesenchymal stem cells-induced ovarian cancer progression via STAT3 inhibition.
PubMed 文献 · Phytomedicine · 2025-10-25

该研究结合45例卵巢肿瘤标本免疫组化与STAT3敲除细胞及小鼠模型,发现癌相关间充质干细胞(CA-MSCs)经STAT3促进卵巢癌增殖转移,桂枝茯苓丸可抑制STAT3-EMT轴阻断肿瘤-基质交互。

要点

  • STAT3激活与CA-MSCs浸润及卵巢癌进展相关
  • 桂枝茯苓丸在体外和小鼠中阻断CA-MSCs促增殖转移
  • 桂枝茯苓丸经抑制STAT3-EMT信号轴干扰肿瘤-基质交互

核心结论

  • STAT3是CA-MSCs诱导卵巢癌进展的关键调控因子。
  • 桂枝茯苓丸靶向STAT3介导的肿瘤-基质交互,具治疗转移性卵巢癌潜力。

研究设计与样本

  • 研究对45例卵巢肿瘤标本行免疫组化分析p-STAT3表达与CA-MSCs浸润模式。
  • 机制研究采用STAT3敲除细胞系,并行癌细胞与CA-MSCs共培养及小鼠异种移植模型。

主要发现

  • 临床标本中STAT3激活与CA-MSCs浸润及卵巢癌进展强相关。
  • CA-MSCs经STAT3介导促进卵巢癌增殖和转移,STAT3敲除细胞反应显著降低。
  • 桂枝茯苓丸在体外和小鼠中有效阻断CA-MSCs诱导的增殖与转移。
  • 桂枝茯苓丸通过抑制STAT3-EMT信号轴破坏肿瘤-基质交互。

临床怎么用

  • 桂枝茯苓丸临床用于卵巢癌维持治疗有显著疗效,本研究为其精准应用提供机制依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ovarian cancer (OC) is the most lethal gynecological malignancy. While carcinoma-associated mesenchymal stem cells (CA-MSCs) in tumor microenvironment are known to facilitate OC progression, the underlying mechanisms remain incompletely understood. The classical herbal formula Guizhi-Fuling Wan (GZFL) has demonstrated significant clinical efficacy in OC maintenance therapy, however, its therapeutic mechanisms require further exploration for precision clinical applications. METHODS: Immunohistochemical analysis of 45 ovarian tumor specimens revealed the clinical significance of p-STAT3 expression and CA-MSCs filtration patterns. Mechanistic studies employed STAT3 knockout (KO) cell lines. To evaluate the tumor-promoting effects of CA-MSCs and the therapeutic potential of GZFL, cancer cells were co-cultured with CA-MSCs and assessed using anti-proliferation, 3D spheroid formation, transwell invasion assays, and in vivo xenograft models. EMT-related protein expression was assessed in co-culture systems to further validate the biological activity of GZFL. RESULTS: Clinically, STAT3 activation strongly correlated with CA-MSCs infiltration as well as with OC progression. We found that CA-MSCs promote OC proliferation and metastasis through a mechanism mediated by STAT3, as STAT3 KO cells showed markedly reduced responsiveness. GZFL effectively blocked CA-MSCs-induced proliferation and metastasis both in vitro and in mice. Further molecular analyses revealed that GZFL disrupted the tumor-stromal crosstalk by suppressing the STAT3-EMT signaling axis. CONCLUSION: Our study identifies STAT3 as a key regulator of CA-MSCs-induced OC progression and highlights the therapeutic potential of GZFL, which targets the STAT3-mediated tumor-stromal crosstalk. Our findings provide crucial mechanistic basis for advancing the clinical application of GZFL for the treatment of metastatic OC.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Xue M, Bu Z, Ke K, et al. Guizhi-Fuling Wan suppresses carcinoma-associated mesenchymal stem cells-induced ovarian cancer progression via STAT3 inhibition. Phytomedicine. 2025. PMID: 41177013. doi:10.1016/j.phymed.2025.157475

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。